Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05704348

Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy

Conditions: Gastroesophageal Reflux

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 550
Sponsor: Helse Forde

Location: Norway

Summary

The goal of this clinical trial is to test gastropexy as a measure to reduce reflux in morbidly obese patients being submitted to sleeve gastrectomy. The main questions it aims to answer are:Does gastropexy reduce reflux symptoms? Does gastropexy reduce objective evidence of reflux? Participants will be randomized to gastropexy or no gastropexy, and researchers will compare these groups to see if reflux (symptoms / objective evidence of) is different in the two groups.

Eligibility Criteria

Inclusion Criteria:Patients planned for bariatric surgery with primary LSGExclusion Criteria:Age below 18 yrsUse of ARM for other reasons than refluxPrevious antireflux surgeryInability to comprehend and respon to patient related outcome (PRO) questionnaire

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05704348). StuddyBuddy aggregates publicly available trial information.